Joseph K. Belanoff
Board Member
Corcept Therapeutics Inc (CORT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $1,182,333 | $15,303,551 |
| 2024 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $1,140,533 | $9,890,081 |
| 2023 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $1,083,333 | $9,337,734 |
| 2022 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $895,833 | $7,352,757 |
| 2021 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $843,750 | $10,984,638 |
| 2020 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $769,567 | $5,762,102 |
| 2019 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $707,525 | $4,958,970 |
| 2018 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $679,792 | $6,314,617 |
| 2017 | Corcept Therapeutics Inc (CORT) | M.D., Chief Executive Officer and President | $647,333 | $4,271,452 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.